2,2-Difluoro-7-oxa-bicyclo[4.1.0]heptane, 97.0%, 250mg

1/? first red plate 530 nm in slide for incident illumination of iScope models for polarization

2-Aminophenylacetylene, 98.0%, 10g

Methyl 3-chloro-1H-indazole-5-carboxylate, 98%, 1g

LETERMOVIR, 95%, 100mg

1,6-Dimethyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 100mg

cis-3-Octen-1-ol>95.0%(GC)25mL

(Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) bis(2-methylacrylate), 95.0%, 500ml

2,3-Dihydro-1,4-benzodioxin-6-ylmethylamine, 95.0%, 10g

6-Methylpyrido[2,3-b]pyrazine, 95.0%, 250mg

3-(4-Chlorophenyl)piperidine, 95.0%, 1g

tert-Butyl 3-formylmorpholine-4-carboxylate, 95.0%, 1g

N-methyl-2-(1H-pyrazol-4-yl)ethanamine dihydrochloride, 95.0%, 1g